- Home
- / Midatech Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Midatech Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
£0
2023-04-21
Market Capitalization
£31.2 M
2023-04-21
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 5.8M | 674.0K | 343.0K | 578.0K | 699.0K | 381.0K | |
| Cost of goods sold | 1.3M | ||||||
| Gross profit | 4.5M | 689.0K | 355.0K | 602.0K | 721.0K | 395.0K | 31.0K |
| Gross profit margin, % | 103.7% | ||||||
| Operating expense total | 17.8M | 11.5M | 9.9M | 7.2M | 9.1M | 8.0M | 9.1M |
| Depreciation and amortization | 1.5M | 1.3M | 13.6M | 403.0K | 343.0K | 283.0K | 254.0K |
| EBITDA | (13.2M) | (10.8M) | (9.6M) | (6.6M) | (8.4M) | (7.6M) | (9.0M) |
| EBITDA margin, % | -1985.6% | ||||||
| EBIT | (16.3M) | (12.1M) | (22.9M) | (7.0M) | (8.7M) | (7.8M) | (9.3M) |
| EBIT margin, % | -2060.4% | ||||||
| Interest income | 2.0K | 8.0K | 1.0K | 29.0K | 83.0K | 167.0K | |
| Interest expense | 587.0K | 97.0K | 34.0K | 44.0K | 53.0K | 41.0K | 165.0K |
| Pre tax profit | (17.1M) | (11.9M) | (23.5M) | (6.1M) | (8.5M) | (7.5M) | (6.0M) |
| Income tax expense | (2.0M) | (1.8M) | (1.3M) | (646.0K) | (832.0K) | (406.0K) | (250.0K) |
| Net Income | (15.0M) | (10.1M) | (22.2M) | (5.5M) | (7.7M) | (7.1M) | (5.7M) |